Emme
Healthcare Software · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1370 S Flower St, Los Angeles, Californi...Phone Number
(213) 748-7147Website
www.emme.comRevenue
<$5 MillionIndustry
About Emme
Emme is a healthcare technology company with a mission to put women's health in women's hands, starting with birth control. Their first product, the Emme Smart Case and app, is an integrated technology-enabled solution designed to safeguard the birth control experience and help reduce the rate of missed pills. The Emme Smart Case uses patent-pending, multi-sensor technology to track when pills are taken. The smart case syncs with the app to send persistent customized reminders until the dose is taken and provides contraceptive guidance when needed. The app also offers users a comprehensive view of their health by supporting cycle, mood, and side effect tracking. Emme was co-founded in 2017 by Amanda French and Janene Fuerch, MD. The pill forever changed women's health in 1960-Emme is making it compatible with the 21st century.Explore more
SIC Code 73,737NAICS Code 51,513Show moreEmme Org Chart
Compare Similar Companies to Emme
Compare insights from companies similar to Emme, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Emme Tech Stack
A closer look at the technologies used by Emme
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Emme
Sign Up For FreeTo access detailed company insights
Emme is a healthcare technology company with a mission to put women's health in women's hands, starting with birth control. Their first product, the Emme Smart Case and app, is an integrated technology-enabled solution designed to safeguard the birth control experience and help reduce the rate of missed pills. The Emme Smart Case uses patent-pendin... Read More